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Introduction
Apoptosis, or programmed cell death, accompanies
human ovary from the moment of birth. While it is a
quite well-known process at the reproductive age
[1,2,10-13,15-17,22,30,41], there are very few reports
on that question when referring to postmenopausal age
[14,23,37].
At the reproductive age, ovaries are hormonally
active glands, in which the process of apoptosis is very
intensive and related mainly to granulosa and theca
cells. Apoptosis restricts the number and development
of ovarian follicles causing their atresia before they are
capable of ovulation [26]. It also intensifies degenera-
tive processes in already formed follicles, and causes
germinal involution [9,11,27,38]. It is a natural, phys-
iological process which provides organ homeostasis
and protects cells from improper functioning
[12,15,37,39]. 
Gonadoliberin, gonadotrophin, estrogens and
androgens [21,29] and also growth factors: insulin
growth factor 1 (IGF-1) and its binding proteins,
fibroblast growth factor β (FGF-β), epithelial growth
factor (EGF), tumor growth factor-α (TGF-α) and
tumor necrosis factor-α (TNF-α) [3,28,34] are consid-
ered as the most important factors regulating apoptosis
in ovarian granulosa cells. 
Commonly applied methods to demonstrate apop-
tosis in human ovary at the reproductive age include
TUNEL method and detection of caspase-3
[1,7,10,12,20,22,27]. The TUNEL method is highly
specific and allows identification of apoptotic cells
even at early stages of apoptosis [1,12,20,22,33]. Sub-
sequently, the method for detecting caspase-3, an exe-
cutioner enzyme in the apoptosis, proves that the
process of apoptosis in female ovarian granulosa cells
is completed [7,10,27]. While these methods are also
applied to assess effectiveness of chemotherapy in
ovarian neoplasms, so far, they have not been used in
research on postmenopausal ovary [20].
The structure of a human ovary changes with age.
At the reproductive age, an ovary is distinctly divided
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into cortex filled with follicles at various stages of
development, and medulla composed of loose connec-
tive tissue with elastic fibres, single myocytes, blood
and lymphatic vessels and nerves. After menopause
the volume of an ovary is considerably reduced. Such
an ovary has no longer follicles and its stroma is com-
posed mainly of fibrous connective tissue, corpora
albicantia, blood and lymphatic vessels, and nerves.
Corpora albicantia are composed of collagen fibres
and connective tissue cells, among them: fibroblasts,
myofibroblasts and macrophages [14,32,35,40,41].
Early manifestations of the ovarian aging (also called
perimenopause) are related to the disturbed function of
the follicle apparatus [5,24,37]. Clinical symptoms
are: diminished fertility, significant percentage of mis-
carriages and increased chromosomal aberrations. Per-
imenopausal women have fewer granulosa cells per
one follicle, lowered production of steroid hormones,
especially progesterone, and reduced production of
inhibin. Granulosa cells in these women are exposed to
oxygen deficiency [12,18,25,36]. We still do not know,
however, if there are any differences in the structure
and function of an ovary depending on the lapse of
time from the last menstruation, and there are very few
reports on that issue [5,14].
The aim of the present study was to investigate the
role of apoptosis in ovarian cells in postmenopausal
women. That is why we decided to demonstrate how
intensity of apoptosis and structure of a female ovary
change during the postmenopause period depending
on the lapse of time from the last menstruation. 
Materials and methods
Patients. The study involved 30 postmenopausal women who did
not use substitutive hormone therapy before, and had their ovaries
removed by laparotomy due to non-neoplastic diseases of the
uterus. The Bioethical Commission gave its consent for this study.
All cases were diagnosed at the Department of Reproduction and
Gynecology, Pomeranian Medical University, Szczecin.
The women were divided into 3 groups depending on the time
that had passed since the last menstruation. Group A (12 patients)
consisted of women who had their last menstruation no more than
5 years earlier. In group B (10 patients) menopause occurred 5 to
10 years earlier. Group C (8 patients) was composed of patients
who had the last menstruation over 10 years earlier.
Hormone measurements. In all the patients concentrations of fol-
litropin (FSH) and estradiol (E2) in blood plasma were measured
using ELISA method enzyme immunoassay kit (Spi-Bio France). 
Morphology. Ovarian tissue (cortex and medulla) was obtained
during surgery. For morphological studies, ovaries were fixed in
Bouin`s solution and 4% formalin and embedded in paraffin. Sec-
tions were cut from the respective parts of ovaries. Morphological
analysis was carried out after hematoxylin-eosin (H+E) staining.
Histochemistry. For histochemical detection of apoptotic cells (in
situ localization of fragment DNA), the TUNEL method was used
(Apo-DETEK, and horseradish peroxidase-DAB In situ detection
system, Enzo-Diagnostics, USA). Following deparaffinization and
rehydration, tissue sections were digested with proteinase K for 15
min at room temperature. Endogenous peroxidase activity was
blocked with 3% hydrogen peroxide in PBS. Sections were incu-
bated for 1 h with TdT and Bio-16-dUTP in a humidified chamber
at 37°C, followed by strepavidin-biotinylated horseradish peroxi-
dase and diaminobenzidine (DAB) as chromogen. The sections
were counterstained with hematoxylin, dehydrated, mounted, and
coverslipped. For negative control, incubation with TdT was omit-
ted.
Immunohistochemistry. The expression of caspase-3 positive
cells was determined immunohistochemically in paraffin-embed-
ded specimens fixed in 4% buffered formalin. The slides were
heated in citrate buffer, pH=6.0 for 30 min. in a water bath at 96°C.
The sections were next incubated for 1 h at room temperature in
dark, humidified chamber with rabbit polyclonal anti-human cas-
pase-3 antibody (Dako, Denmark). Detection of anti - caspase-3
antibody was performed using Dako EnVision System, Alkaline
Phosphatase - Fast Red. Levamisole was used as an inhibitor of
endogenous alkaline phosphatase (Sigma, USA). Fast Red was
used to visualize the immunohistochemical  reaction. Finally, the
sections were counterstained with Mayer's hematoxylin. After each
step, sections were rinsed with Tris-buffered saline (TBS). Control
sections  were incubated with TBS instead of the primary antibody.
Statistical analysis.  The Kruskal-Wallis test was used for statisti-
cal analysis. The accepted significance level was p<0.05.
Results
Age of the examined patients 
In group A average age of the patients was 47.1±1.8
years (M±SD), in group B: 54.6±2.1 (M±SD), and in
group C: 59.9±1.2 (M±SD). Considerable age differ-
ences were found between women from groups: A and
B, B and C, and A and C (p<0.05).
The levels of FSH and E2 in serum of the exam-
ined patients
In group A, the mean E2 concentration was 20.3
pg/mL ± 6.9 (M±SD), in group B - 21.6 pg/mL ± 8.3
(M±SD) and in group C - 13.8 pg/mL ± 3.2 (M±SD)
(Fig. 1).  
The mean E2 serum concentrations did not signifi-
cantly differ from each other (p>0.05).
In group A, the mean FSH concentration was 51.1
mUI/mL ± 15.8 (M±SD), in group B - 55.8 mUI/mL ±
19.7 (M±SD), and in group C - 87.6 mUI/mL ± 11.0
(M±SD).
Considerable differences in the mean serum FSH
values were found between the examined groups of
women (between groups A and B, B and C, and A and
C) (Fig. 2) (p<0.05).
Morphology (H+E staining) 
In the ovaries of group A women, numerous corpora
albicantia and well-developed fibrous connective tis-
sue as well as abundant blood and lymphatic vessels
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and nerves were observed (Fig. 3). Group B women
had only few, partially fragmentated corpora albicantia
in their ovaries, and their blood vessels were partly
hyalinizated (Fig. 4). Morphological picture of the
ovaries in group C was significantly different from that
of group A. The ovaries in group C contained only sin-
gle corpora albicantia located in the medullary part as
well as thinned blood vessels and few lymphatic ves-
sels and nerves (Fig. 5).
Histochemical results (the TUNEL method)
In the women examined no more than 5 years after
menopause (group A), the number of TUNEL-positive
cells was high and concerned mainly to vascular
endothelial cells, connective tissue cells and corpora
albicantia. The highest expression of TUNEL-positive
cells was observed in connective tissue cells of stroma
and in connective tissue cells of corpus albicans. The
expression of TUNEL-positive cells was observed in
vascular myocytes and endothelial cells. (Fig. 6, 7 and
8). The more years passed from the last menstruation,
the fewer TUNEL-positive cells were found. In group
B, TUNEL-stained nuclei appear in connective tissue
cells of stroma and in vascular endothelial cells. Only
single TUNEL-positive nuclei were observed in vas-
cular myocytes of the hyalinizated artery (Fig. 9) and
in connective tissue cells of corpora albicantia. In
group C, TUNEL-positive nuclei were not found in the
examined ovaries at all (Fig. 10).
Immunohistochemical results  
(caspase-3 reaction) 
In the ovaries of group A women, the highest level of
caspase-3 expression was observed in cytoplasm of
connective tissue cells (Fig. 11),  in vascular myocytes
and in corpora albicantia. With patients` age, expres-
sion of caspase-3 decreased. In group B, single cas-
pase-3 positive cells were found among connective tis-
sue cells, in vascular myocytes and corpora albicantia.
No caspase-3-possitive cells were observed in group C
(Fig. 12).
Discussion
Considering the discussions on the role of ovaries
in postmenopausal women, we examined hormone
concentration in blood serum. We also conducted mor-
phological, histochemical and immunohistochemical
analyses of ovaries in postmenopausal women depend-
ing on the lapse of time from their last menstruation. 
Significant differences were found in serum FSH
concentrations between the particular groups (A, B,
C), whereas estradiol concentrations in serum did not
considerably vary depending on the length of time
from the last menstruation. Our results are consistent
with those reported by other authors [5,6,31]. As we
know from written sources, FSH concentration in
women at the reproductive age is between 5 and 15
mIU/mL, and E2 concentrations between 50 and 520
pg/mL, unless the cycle is stimulated. As Buckler and
Casella et al. [6,8] claim, FSH and E2 are very sensi-
tive markers of endocrinological changes in the organ-
ism of perimenopausal woman. Concentration of FSH
increases as first in perimenopausal period signalizing
the onset of menopause; then it remains at maximum
values until senium begins. Estradiol concentration
practically does not change following the menopause.
Numerous authors say that serum estradiol concentra-
tions lower than 50 pg/mL cause disappearance of
menstruation and appearance of menopause symptoms
which vary individually [6,8,19]. 
Ovaries of postmenopausal women are known to
vary in size and morphology [4,5,14,37]. Focchi et al.
[14] state that the number and size of corpora albican-
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Fig. 1. The mean serum estradiol concentration (pg/mL) in the
examined women. Significant differences were not observed in the
analyzed groups of patients (mean ± SD), p>0.05.
Fig. 2. The mean serum FSH concentration (mIU/mL) in the
examined patients. Significant differences were noted between the
examined groups of women (mean ± SD), *p<0.05.
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Fig. 3. Ovary of group A postmenopausal women (examined no more than 5 years after menopause). Numerous corpora albicantia
(asterisks), well developed connective tissue and abundant blood vessels. H-E staining (magnification ×160). Fig. 4. Ovary of group B
postmenopausal women (examined from 5 to 10 years after menopause). Only few corpora albicantia (asterisks) and hyalinizated artery
(arrow). H-E staining (magnification ×160). Insert represents the hyalinizated artery (magnification ×330). Fig. 5. Ovary of group C
postmenopausal women (examined more than 10 years after menopause). Single corpora albicantia (asterisk) located in the medulla part
and thinned blood vessels (arrows). H-E staining (magnification ×160). Fig. 6. Ovary of group A postmenopausal women (examined no
more than 5 years after menopause). TUNEL-stained nuclei appear mainly in connective tissue cells (arrows), vascular myocytes (black
arrowheads) and endothelial cells (green arrowheads) (magnification ×330). Fig. 7. Ovary of group A postmenopausal women (exam-
ined no more than 5 years after menopause). Corpus albicans (CA). TUNEL-stained nuclei appear mainly in connective tissue cells of
corpus albicans (white arrowheads) and in connective tissue cells of stroma (arrow) (magnification ×330). Fig. 8. Ovary of group A post-
menopausal women (examined no more than 5 years after menopause). The border between corpus albicans (CA) and stroma. TUNEL-
positive nuclei can be seen in connective tissue cells of corpus albicans (white arrowheads) and in connective tissue cells of stroma
(arrows) (magnification ×330). 
tia in particular woman depend on the number of ovu-
lations at reproductive age and phagocytic activity,
which varies individually and decreases as the time
from the last menstruation passes. The size of ovaries
in postmenopausal women depends on the number of
nonresorbed corpora albicantia. 
The results presented in this study show that the
structure of female ovaries after menopause depends
on the time that passed from the last menstruation. In
the ovaries of the patients who had menopause less
than 5 years earlier, numerous corpora albicantia and
well-developed fibrous connective tissue can be found
as well as abundant blood and lymphatic vessels, and
nerves. Group B women have fewer, partially frag-
mentated corpora albicantia in their ovaries. Blood
vessels in these ovaries are hyalinizated, which means
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Fig. 9. Ovary of group B postmenopausal women (examined from 5 to 10 years after menopause). Stroma of the ovary and the hyalin-
izated artery. TUNEL-stained nuclei appear in connective tissue cells (arrows) and in vascular endothelial cells (green arrowheads). Only
single TUNEL-positive nuclei can be seen in vascular myocytes of the hyalinizated artery (black arrowheads) (magnification ×330). 
Fig. 10. Ovary of group C postmenopausal women (examined more than 10 years after menopause). Stroma and blood vessel of the ovary.
No TUNEL-positive nuclei (magnification ×330). Fig. 11. Ovary of group A postmenopausal women (examined no more than 5 years
after menopause). The highest level of caspase-3 expression was observed in cytoplasm of connective tissue cells (arrows) (magnifica-
tion ×160). Fig. 12. Ovary of group C postmenopausal women (examined more than 10 years after menopause). No caspase-3-positive
cells (magnification ×160).
that their diameters are reduced, and walls are thicker
comparing to the ovarian vessels in group A. In the
ovaries of the oldest women from group C a blurring
border line between cortex and medulla was observed
as well as single corpora albicantia located mainly in
the medullary part, few blood and lymphatic vessels
and nerves.  Our results are consistent with those
reported by Focchi et al. [14] who, additionally, deter-
mined the percentage of corpora albicantia in the
whole structure of an ovary. 
However, histochemical (the TUNEL method) and
immunohistochemical (caspase-3 reaction) analyses
that we carried out prove that the process of apoptosis
in ovaries of women examined up to 5 years after
menopause is most intensive in corpora albicantia,
arterial walls and in the area of blood vessels. The
longer the time from the menopause, the less active the
process is. In group B women, whose mean age was 54
years, the mean serum estradiol concentration was
21.6 pg/mL, and the mean FSH concentration - 55.8
mIU/mL. Less numerous TUNEL-positive cells were
found among vascular endothelial cells, connective tis-
sue cells, vascular myocytes and corpora albicantia.
Also single caspase-3 positive cells were observed
among connective tissue cells, vascular myocytes and
corpora albicantia. In group C women, whose mean
age was 59 years, the mean estradiol concentration
was 13.8 pg/mL, and the mean FSH concentration -
87.6 mIU/mL. Neither TUNEL-positive cells nor cas-
pase-3 positive cells were found. The presented data
show the coincidence of the decreasing ovarian apop-
tosis and increasing serum FSH concentration. Perhaps
in women who had the last menstruation over 10 years
earlier, the apoptosis does not appear any more or,
depending on the patient's age, it is barely active. The
written sources lack information on this tissue. It is
probable that the decline of apoptosis is also related to
the progressing decline of the ovarian steroidogenesis
which does not only refer to estrogen, but also andro-
gen production. There are reports on the decreasing
activity of  key steroidogenic enzymes such as 17-β-
steroid and 3-β-steroid dehydrogenase, aromatase P-
450 as well as data being the evidence for the decreas-
ing activity of both LH and FSH receptors and steroid
hormone receptors [4,5,31]. Hopefully, the research on
ovarian apoptosis and steroidogenesis will be carried
on, and the results will have clinical implications.
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